Certara to Participate in the Jefferies Global Healthcare Conference
Certara (Nasdaq: CERT), a global leader in biosimulation, announced its participation in the Jefferies Global Healthcare Conference.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Certara (Nasdaq: CERT), a global leader in biosimulation, announced its participation in the Jefferies Global Healthcare Conference.
The event will take place on June 5th, 2024, at 11:30AM ET.
Company management will present at the conference, and a live webcast will be available on Certara’s investor relations website.
The webcast replay will be accessible for at least 90 days.
Positive
- Certara's participation in a high-profile event like the Jefferies Global Healthcare Conference enhances its visibility and credibility in the industry.
- The live webcast provides transparency and allows broader investor access to the presentation.
- The replay availability for 90 days ensures prolonged access for interested stakeholders.
Negative
- The press release lacks specific financial or clinical data, making it difficult to assess immediate impact on stock performance.
- No new product announcements or strategic partnerships were disclosed, which may disappoint some investors looking for tangible updates.
Details
News Market Reaction – CERT
The recorded move for CERT in the trading session of this news was +2.49%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
RADNOR, Pa., May 29, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the Jefferies Global Healthcare Conference.
Company management will present at 11:30AM ET on Wednesday, June 5th, 2024.
A live webcast of the event will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 90 days thereafter.
About Certara
Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include nearly 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. Learn more at www.certara.com.
Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com
Media Contact:
Alyssa Horowitz
Pan Communications
certara@pancomm.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.